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Summary Sexually transmitted diseases and infections (STDIs) are 
known to have a major socioeconomic and biologic impact, particularly 
on women (e.g., sterility, ectopic pregnancies, neoplasms, etc.) and 
fetus (intrauterine and perinatal mortality, infection, malformations). 
Sex workers do not use health services appropriately and are a high-
risk category. Despite this evidence, data on prostitution and STDIs in 
some countries are limited. Sexual health medicine is involved in the 
community by identifying and minimizing the STDI problems through 
laboratory screening, diagnostic testing, education, and research.
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INTroduCTIoN
 The knowledge of irresponsible sex behavior 
and sexually transmitted diseases and infections 
(STDIs) in the risk population (particularly in street 
workers) is important for fostering appropriate 
health services in the risk category. Sexually trans-
mitted diseases (STDs) are known to have a ma-
jor socioeconomic and biologic impact, particularly 
on women (e.g., sterility, ectopic pregnancies, neo-
plasms, etc.) and fetus (intrauterine and perinatal 
mortality, infection, malformations). Healthy sexual 
relations, including freedom from STDs is the area 
of sexual health medicine. Sex workers do not use 
health services appropriately and are a high-risk 
category. Despite this evidence, data on prostitu-
tion and STDs in some countries are limited. The 
treatment of individuals and the contact tracing 
and treatment of their partners is an essential part 




 In a survey of sex workers carried out from 
January 2001 till January 2004 by use of a ques-
tionnaire in the area of Padua (north-east Italy), 
135 sex workers were approached (aged between 
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17 and 27 years; 50 girls had come from Eastern 
Europe (Albania, Romania, ex-Yugoslav states, 
Russia), 38 from Africa (Nigeria, Ghana) and 10 
from the Caribbean). Most sex workers (85%) did 
not use a condom with nonpaying partners (boy-
friends, fiancés, and pimps) (1). As for specific 
knowledge of the various STDs, AIDS was known 
to 93% of the sex workers, syphilis to 56%, gon-
orrhea to 23%, genital herpes to 29%, scabies 
to 24%, viral hepatitis B to 16%, nongonococcal 
urethritis/vaginitis (chlamydial infections) to 8%, 
and condylomas (HPV infections) to 6% of the re-
sponding persons (1). 
 Due to worldwide information campaigns, al-
most all sex workers were aware of AIDS but, de-
spite their relatively satisfactory educational level, 
they knew very little of other STDs and were al-
most completely ignorant of STD sequels like viral 
hepatitis, urethritis, nongonococcal vaginitis, chla-
mydial infections or HPV infections (condylomas).
 With a rising incidence of sexually transmitted 
infections (STIs) across Europe, it is appropriate 
to look at different arrangements for the future. 
The developing plans in the United Kingdom (UK) 
are described with its national sexual health strat-
egy, targets to be met, and plans for greater use 
of nurses and primary care and possible future de-
velopments using the internet. In some countries 
like the UK, special hospitals have been estab-
lished for those with venereal diseases, i.e. Lock 
Hospitals (2). Specialist care in Europe for STIs 
is provided by dermatovenereologists but most 
patients consult primary care providers in the first 
instance. Care may be guided by national man-
agement guidelines in some countries and recent 
European management guidelines may be of as-
sistance too (2).  
 Services in western Europe are, therefore, pro-
vided by individual doctors on the whole rather 
than by clinics or institutions. In eastern Europe, 
while the private sector may be slowly expanding, 
most services are sited in the state sector in der-
matovenereological clinics or polyclinics.  
 There are differences in collecting epidemio-
logical data between western and eastern Europe. 
In the UK and Scandinavia it is very accurate. In 
countries in the West where general practitioners 
look after much of STDs it is not so accurate. 
In eastern Europe it is usually reliable. In North 
America the bulk of service provision is by primary 
care physicians nowadays. The United States of 
America (USA) had a superb nationwide clinic ser-
vice before the Second World War. Nowadays, a 
number of public clinics serve urban centers, often 
run by public health doctors or infectious disease 
physicians, urologists, gynecologists or venereol-
ogists but with a bulk of the service being provid-
ed by nurses working to protocol. The US Public 
Health Service has developed the first manage-
ment guidelines to guide family doctors (2).  
 Family doctors have had a relatively minor role 
in the care of STIs but this is due to change. It 
has always been mandatory for clinics to collect 
epidemiological data. Thus, cases of all STIs are 
counted, including HIV diagnoses and reported to 
the Centre for Disease Surveillance and Control 
(CDSC), part of the Public Health Laboratory Ser-
vice, which is an arm of the Department of Health. 
There is a rising incidence of all STIs in the UK 
(2). This is true across the whole of Europe and, 
with the established link between the presence of 
STIs and the enhanced transmission of HIV infec-
tion, there is considerable concern, particularly in 
eastern Europe.
 It is important to recognize who are the princi-
pal groups at risk of STIs: young, sex workers, gay 
men/lesbians and disadvantaged groups such as 
ethnic minorities, asylum seekers and prisoners.
 There are four initial targets established in the 
Sexual Health Strategy for England and Wales. 
They are as follows: a 25% reduction in gonococ-
cal infections by 2007; an uptake of 80% on offers 
of HIV testing for new attendees at clinics by 2005; 
a 25% reduction of newly acquired HIV infections 
by 2007; the expected uptake of the full 3 doses of 
hepatitis B vaccine in homosexual/bisexual men, 
not naturally immune or previously immunized 
(2). 
 The worldwide epidemic of HIV continues to 
expand in many regions of the world, particularly 
in southern Africa, south and south-east Asia, east 
Asia and eastern Europe and central Asia. Esti-
mates are that at the end of 2005 there were 38.6 
million persons living with HIV infection and that 
4.1 million new infections and 2.8 million deaths 
from HIV occurred during the year (3). World-
wide, societal shifts and behavioral patterns ex-
acerbated by unique developmental vulnerabilities 
create a confluence of factors that place today’s 
adolescents at heightened risks of poor health 
outcomes. Sex education programs should offer 
accurate, comprehensive information while build-
ing skills for negotiating sexual behaviors (4). Girls 
and boys need access to youth development pro-
grams with supportive adults and with educational 
opportunities. In 2002, MTV launched a global 
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multicomponent HIV prevention campaign, “Stay-
ing Alive”, reaching over 166 countries worldwide. 
An evaluation of this campaign focused on three 
diverse sites: Kathmandu, Nepal; Sao Paolo, Bra-
zil; and Dakar, Senegal (5). 
 There was a consistent positive effect of expo-
sure on interpersonal communication across all 
sites, although there were differences among sites 
with regard to whom the respondent talked about 
HIV (5). The Joint United Nations Programme on 
HIV/AIDS 2004 epidemic report indicated that 
nearly 50% of infected people worldwide were 
women, up from 35% in 1985 (6). The preventive 
strategies are focused on gender relatives, eco-
nomics, and migration (GEM) (6). Genital herpes 
simplex virus type 2 (HSV2) is highly prevalent 
worldwide and an increasingly important cause 
of genital ulcer disease (GUD). Continued HSV2 
transmission is facilitated by the large number 
of undiagnosed cases, the frequency of atypi-
cal disease and the occurrence of asymptomatic 
shedding (7). A safe and effective HSV vaccine is 
urgently needed. Out of 25 organisms known to 
be transmitted sexually, travelers are at a greater 
risk of acquiring HIV and other STDs in develop-
ing countries in view of the high prevalence rates 
in these countries, particularly after sexual expo-
sure to local commercial sex workers (CSWs). 
HIV, gonorrhea, syphilis, non-specific urethritis, 
hepatitis B, hepatitis C, and other STDs are a 
significant risk for travelers who engage in unpro-
tected sex, especially with overseas CSWs (8). 
The successes of the United States and other de-
veloped countries in the prevention and treatment 
of pediatric HIV/AIDS have not been replicated in 
the developing world, where children continue to 
become infected with HIV and die from HIV/AIDS 
at astounding rates (9). Establishment of the Clini-
cal Centers of Excellence Network and Pediatric 
AIDS Corps of US pediatric health professionals 
has been proposed by Kline (9). Syphilis and HIV 
infection share behavioral and epidemiologic pat-
terns. The epidemic of early syphilis is associated 
with acquisition and transmission of HIV in devel-
oped countries, mainly in man who have sex with 
men (MSM) (10). These patients are also at risk of 
gonorrhea, Chlamydia infection and L2 Chlamydia 
proctitis. 
 Chlamydia trachomatis is the leading cause 
of bacterial STDs worldwide. A population-based 
cross-sectional study of 344 men and women with 
urogenital chlamydial infections (excluding co-
pathogen infections) presenting to clinics serving 
five US cities from 1995 to 1997 was designed by 
Millman et al. (2006) (11). One hundred and fifty-
three (44.5%) of 344 patients had symptoms con-
sistent with urogenital chlamydial infection (11). 
Future studies might utilize multilocus genomic 
typing to identify chlamydial strains associated 
with clinical phenotypes because of polymorphism 
of chlamydial infections. Gonorrhea is the second 
most often reported STD in the United States fol-
lowing Chlamydia. It is estimated that 600,000 
people are infected in the USA per year (12). From 
1975 through 1997, the national gonorrhea rate de-
clined by 74.3%. In 2003, the Gonococcal Isolate 
Surveillance Project found about 16% of collected 
isolates to be resistant to penicillin and/or tetra-
cycline. Since 1998, the number of ciprofloxacin-
resistant isolates has been increasing, 270 (4.1%) 
being reported in 2003 (12). Based on compari-
sons with international best practice, recommen-
dations are included for improvement in adolescent 
sexual and reproductive health within the Austra-
lian context (13). Australia’s high rates of teenage 
pregnancy and increasing rates of STIs in young 
people reflect on the public health agenda (13). 
Major increases in HIV-1 prevalence in India have 
been predicted (1.7% to 1.1 % in 2000-2004). This 
fall (from 1.7% in 2000 to 1.1% in 2004) is prob-
ably due to the rising condom use by men and 
female sex workers in South India and education 
programs for sex workers to control HIV-1 in India 
(14). The Cape Town Equity Gange Project since 
1994 is presented as an example of response to 
the challenge of inequity and approach to improv-
ing health resources (15). In addition to technically 
efficient interventions (initiative and communica-
tion), implementation of pro-eguity policies re-
quires involvement of affected communities (15). 
Public health programs for HIV infected at-risk 
populations can operate effectively in Emergency 
Departments (EDs). The ED notified 77.3% of in-
dividuals testing positive in Cincinnati (USA) and 
referred them to infectious disease specialists. 
EDs should have a rapidly expanding role in the 
national public health system (16). 
 Sexual health medicine is very important nowa-
days. As Waugh says: “Sexual health medicine is 
a specialized area of medical practice concerned 
with healthy sexual relations, including freedom 
from sexually transmitted infections, unplanned 
pregnancy, coercion on physical or psychological 
discomfort associated with sexuality”(17). 
CoNCLuSIoN
 With the rising incidence of STDIs, the present 
arrangements are not adequate. At the dawn of 
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the third millennium, non-communicable diseases 
are sweeping the entire globe. It is predicted that, 
by 2020, non-communicable diseases will cause 
seven out of every ten deaths in developing coun-
tries (18). Thus, understanding the sexual behav-
ior of human beings and appropriate prevention 
is the main goal of Public Health Services. The 
public health challenge worldwide is to keep unin-
fected and to treat and care the infected. 
 This is a global view of the main diseas-
es and their impact on populations living in 
low as well as good income nations. Preven-
tative strategies must take into account the 
growing trend of risk factors related to STDIs. 
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